BCC Research Projects 13.1% CAGR from 2024, with Market
Growing from $16.4 Billion in 2024 to
$30.2 Billion by 2029
BOSTON, July 15,
2024 /PRNewswire/ -- Metabolomics: Technologies and
Global Markets is about studying tiny molecules in our bodies to
understand health and disease better. It looks at advanced tools
used for this research and how they're being adopted worldwide. The
report covers market trends, key companies, and future
opportunities in the field, showing how metabolomics is making a
big impact on science and industry.
Market Expansion and Revenue Surge
"According to the latest BCC research study, the demand for
Metabolomics: Technologies and Global Markets expected to
grow from $16.4 billion in 2024 and
will reach $30.2 billion by the end
of 2029 at a compound annual growth rate (CAGR) of 13.1% from 2024
to 2029."
This report thoroughly examines the global market for
metabolomics technologies. It estimates both current and past
market revenues, breaking them down by product type, medical
conditions, applications, and regions.
Some Interesting Facts about Green Tires Market
Metabolomics can identify unique metabolic patterns in forensic
investigations and predict how individuals will respond to
medications, enabling personalized treatment plans. It can also
analyze breath samples for non-invasive disease diagnosis and
detect metabolic changes related to aging and psychological
conditions, improving diagnostics and treatments.
Factors contributing to this growth include:
- Technological advancements.: Technological advancements
are improvements in tools and methods that make tasks easier and
more efficient, like smartphones, faster computers, or advanced
medical devices. They help us solve problems and improve our daily
lives.
- Increasing healthcare expenditure.: Increasing
healthcare expenditure means that more money is being spent on
healthcare services, treatments, and medications. This can be due
to factors like an aging population, new medical technologies, and
rising costs of healthcare services.
- Precision medicine and personalized healthcare.:
Precision medicine and personalized healthcare mean tailoring
medical treatments and interventions to individual characteristics
such as genetics, lifestyle, and environment. Instead of a
one-size-fits-all approach, doctors use information specific to
each person to make decisions about prevention, diagnosis, and
treatment, aiming to achieve better outcomes and reduce side
effects.
- Drug discovery and development.: Drug discovery and
development is the process of finding new medications and bringing
them to market. It involves identifying potential drug candidates,
testing their safety and effectiveness through clinical trials, and
obtaining regulatory approval before they can be prescribed to
patients. This process can take many years and involves
collaboration between scientists, researchers, clinicians, and
regulatory agencies to ensure that new drugs are safe and effective
for treating diseases.
Request a Sample Copy of the Metabolomics:
Technologies and Global Markets
Report Synopsis
|
Report
Metrics
|
Details
|
|
Base year
considered
|
2023
|
|
Forecast Period
considered
|
2024-2029
|
|
Base year market
size
|
$14.7
billion
|
|
Market Size
Forecast
|
$30.2
billion
|
|
Growth Rate
|
CAGR of 13.1% for the
forecast period of 2024-2029
|
|
Segment
Covered
|
Product, Indication,
Application, and Region
|
|
Regions
covered
|
North America, Europe,
Asia-Pacific, and Rest of the World (RoW)
|
|
Countries
covered
|
China, India, Japan,
Malaysia, Singapore U.S., Canada, Mexico, Germany, U.K., France,
Italy, and Spain
|
|
Key Market
Drivers
|
- Technological
advancements.
- Increasing
healthcare expenditure.
- Precision medicine
and personalized healthcare.
- Drug discovery and
development.
|
Market Segmentation
The Global Market for Metabolomics: Technologies and Global
Markets can be categorized into various segments:
- By Product
In metabolomics, technologies are
divided into two main categories: separation techniques and
detection techniques. Separation techniques, like chromatography
(GC and LC), isolate individual metabolites from complex mixtures
for easier analysis. Detection techniques, such as mass
spectrometry (MS) and NMR spectroscopy, then identify and measure
these metabolites, providing detailed insights into their
structures and quantities. Together, these methods enable
researchers to explore and understand the intricate biochemical
processes in living organisms.
- By Indication
In metabolomics, studies are
categorized by various health conditions, including cancer,
cardiovascular disorders, neurological disorders, inborn errors of
metabolism, and others. Researchers use metabolomics to identify
unique metabolic patterns associated with these conditions. For
instance, in cancer, it helps detect specific metabolic changes
that may aid in early diagnosis or monitoring treatment responses.
In cardiovascular and neurological disorders, it offers insights
into metabolic disturbances linked to disease progression. For
inborn errors of metabolism, it assists in understanding and
managing genetic disorders affecting metabolic pathways. These
insights contribute to developing more targeted therapies and
personalized treatment approaches across different medical
conditions.
- By Application
In metabolomics, applications
span biomarker discovery, drug development, toxicology testing,
nutrigenomics, functional genomics, and other areas. Biomarker
discovery involves identifying specific molecules that indicate
disease presence or treatment response. Drug discovery uses
metabolomics to find potential new medications by studying
metabolic pathways. Toxicology testing assesses how substances
affect metabolism and health. Nutrigenomics examines how nutrients
influence metabolism and genetics. Functional genomics studies how
genes interact with metabolites to understand biological functions.
These applications enhance our understanding of health, disease,
and personalized medicine through detailed metabolic analysis.
- By Region
Metabolomics technologies are
utilized across different regions: North
America, Europe, APAC
(Asia-Pacific), and the Rest of
World. Each region contributes uniquely to the adoption and
advancement of these technologies in research, healthcare, and
industry. North America and
Europe are leaders in innovation
and market adoption, with extensive research and development
activities. APAC is rapidly growing, driven by increasing
healthcare investments and research initiatives. The Rest of World
region encompasses diverse contributions and emerging markets,
fostering global collaboration in metabolomics research and
applications.
this report on global market for metabolomics: technologies
and global markets provides comprehensive insights and analysis,
addressing the following key questions:
- What is the projected market size and growth rate of the
Metabolomics Technologies market?
The global medical robotics and computer-assisted surgery market is
projected to grow from $14.4 billion
in 2023 to $30.2 billion in 2029 at a
compound annual growth rate (CAGR) of 13.1 % during the forecast
period.
- What are the key factors driving the growth of the
Metabolomics Technologies market?
The growth of the
metabolomics technologies market is propelled by advancements in
analytical techniques, expanding applications in clinical research
and personalized nutrition, increasing integration into
pharmaceutical and biotechnology research, and rising demand in
agriculture and food sciences.
- What segments are covered in the global Metabolomics
Technologies market?
The global Metabolomics Technologies market is segmented based
on the product type, Indication, application and geographic
region.
- By Type, which segment will dominate the market by the end
of 2028?
The surgical robotics systems segment will dominate the market by
the end of 2028.
- Which region has the highest market share in the
Metabolomics Technologies market?
North America holds the highest share in the
market.
Some of the Key Market Players Are:
- AGILENT TECHNOLOGIES INC.
- BIO-RAD LABORATORIES INC.
- BRUKER
- DANAHER CORP
- MERCK KGAA
- SHIMADZU CORP.
- THERMO FISHER SCIENTIFIC INC.
- WATERS CORP.
Directly Purchase a copy of the
report with BCC Research.
For further information or to make a purchase, please get in
touch with info@bccresearch.com.
About BCC Research
BCC Research provides objective, unbiased measurement and
assessment of market opportunities with detailed market research
reports. Our experienced industry analysts' goal is to help you
make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St. Ste 16,
Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our
media page for access to our market research library.
Data and analysis extracted from this press release must be
accompanied by a statement identifying BCC Research LLC as the
source and publisher.
Logo:
https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/metabolomics-technologies-market-expected-to-reach-30-2-billion-by-2029--302196718.html
SOURCE BCC Research LLC